Related Experiment Video
Updated: Jun 26, 2025

12:08
Diagonal Method to Measure Synergy Among Any Number of Drugs
Published on: June 21, 2018
18.5K
TransFOL: A Logical Query Model for Complex Relational Reasoning in Drug-Drug Interaction
IEEE Journal of Biomedical and Health Informatics
|May 14, 2024
Summary
This study introduces TransFOL, a novel deep learning model for predicting drug-drug interactions (DDIs). TransFOL utilizes knowledge graphs and advanced neural networks to improve DDI prediction accuracy and incorporate complex biomedical factors.
Area of Science:
- Pharmacology
- Bioinformatics
- Artificial Intelligence
Background:
- Predicting drug-drug interactions (DDIs) is vital for drug discovery and safety.
- Traditional wet lab methods for DDI identification are costly and time-consuming.
- Existing deep learning models for DDIs lack comprehensive reasoning capabilities and fail to integrate diverse biomedical factors.
Purpose of the Study:
- To develop an advanced model for predicting drug-drug interactions (DDIs) that overcomes the limitations of existing methods.
- To incorporate complex biomedical factors beyond simple drug pairs into DDI prediction.
- To frame DDI prediction as a link prediction problem on knowledge graphs for enhanced reasoning.
Main Methods:
- Proposed TransFOL, a DDI prediction model integrating Cross-Transformer and Graph Convolutional Networks (GCNs) within a first-order logical query framework.
- Constructed a biomedical query graph to learn entity and relation embeddings.
- Employed an enhancement module to aggregate semantic information and utilized Cross-Transformer for node semantic encoding and GCN for neighbor aggregation.
Main Results:
- TransFOL outperformed state-of-the-art methods on traditional DDI prediction tasks across two benchmark datasets.
- The model demonstrated strong performance and generalization capabilities in more realistic settings with diverse biomedical information.
- Experimental results validated the model's ability to handle complex drug reasoning tasks.
Conclusions:
- TransFOL offers a powerful and generalizable approach for drug-drug interaction prediction.
- The model's ability to integrate complex biomedical factors enhances its applicability in real-world drug discovery and recommendation scenarios.
- This knowledge graph-based approach advances the field of computational pharmacology and drug safety.
Related Concept Videos
Drug-Receptor Interactions
5.1K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
5.1K
Agonism and Antagonism: Quantification
365
When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
365
Quantitative Aspects of Drug-Receptor Interaction
974
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
974
Pharmacokinetic Models: Overview
665
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
665
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
38
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
A recent model describes pravastatin's hepatobiliary excretion,...
38
Drug-Receptor Interaction: Antagonist
2.9K
An antagonist is a drug that binds strongly to a receptor without activating it. An antagonist prevents other molecules, such as neurotransmitters or hormones, from binding to the receptor and triggering a cellular response. Such interaction effectively hinders the normal physiological processes mediated by the receptor, resulting in various pharmacological effects depending on the specific receptor targeted.
Antagonists can be classified as competitive or noncompetitive based on their...
Antagonists can be classified as competitive or noncompetitive based on their...
2.9K

